Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

326.54 -13.03 (-3.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,780,244
Open 332.54
Bid (Size) 326.00 (7)
Ask (Size) 326.50 (1)
Prev. Close 339.57
Today's Range 317.18 - 335.75
52wk Range 65.49 - 497.49
Shares Outstanding 403,646,312
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine
U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine 
From Business Wire News Releases
Novavax Is Set to Win on the Increasing Necessity of Booster Shots
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NVAX stock has dropped a significant amount recently, but this could be a terrific buying opportunity for savvy long-term investors. The... 
Tags MRNA NVAX MRK
From InvestorPlace

Performance

YTD
+192.26%
+192.26%
1 Month
-28.17%
-28.17%
3 Month
-2.78%
-2.78%
6 Month
+83.85%
+83.85%
1 Year
+362.98%
+362.98%

More News

Read More
Where Moderna Stands With Analysts
Tags BZI/AAR MRNA Benzinga
From Benzinga
Why Novavax Fell by 3% Today
Tags PFE JNJ MRNA
From Motley Fool
Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster program
Tags PFE MRNA JNJ
From MarketWatch
Why Moderna Stock Is Falling Today
Tags MRNA DB Market News
From Motley Fool
Moderna Slapped With Sell Rating Despite CDC Authorization For Covid Boosters
From Investor's Business Daily
Corona Doom 2.0: Carter Worth Warns That Vaccine-Maker Moderna May Have Further To Fall. What To Do If You're Long.
Tags Vaccines Small Cap TSLA
From Benzinga
Moderna Slapped With Sell Rating Despite CDC Authorization For Covid Boosters
From Investor's Business Daily
What's the Outlook for Novavax Stock?
Tags BNTX Market News NVAX
From Motley Fool
CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results in booster trial
Tags MRNA PFE JNJ
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.